UNSPSC 51285319: Nifuratel

This classification denotes an antifungal agents and antitrichomonal agents and antiprotozoal, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier U60U6P08SP. European Medicines Agency schedules Nifuratel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09261MIG. Nifuratel generally arises in the molecular formula C10H11N3O5S.

The term NIFURATEL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 21 no. 12 1967, list 7.) NIFURATEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51285319 Nifuratel is a Commodity code representing specific pharmaceutical products purchased by state and local health agencies. The recent opportunities tied to this code do not involve nifuratel itself; instead, they document state and local procurement of other pharmaceuticals and medical supplies — antibiotic tablets (doxycycline, ciprofloxacin) through cooperative purchasing vehicles, and naloxone with drug deactivation systems through traditional competitive bidding. State and local health departments and county health authorities are the primary issuing bodies under this code tier, sourcing critical care and emergency response pharmaceuticals through both piggyback contracts on established cooperative purchasing agreements and direct IFB processes.

The most recent activity appears concentrated in the Southeast, with solicitations from Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract to Chartwell Rx LLC through the MMCAP Infuse cooperative purchasing vehicle in August 2026 for doxycycline and ciprofloxacin tablets on a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB (No. IFB60459723LAS) posted June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the bid response deadline was July 26, 2023. Both opportunities specify full delivery responsibility and cost inclusion in vendor pricing, with standard compliance requirements including drug-free workplace certification and E-Verify authorization.